ATRIAL-FIBRILLATION IS ASSOCIATED WITH AN INCREASED RISK FOR MORTALITY AND HEART-FAILURE PROGRESSION IN PATIENTS WITH ASYMPTOMATIC AND SYMPTOMATIC LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION - A RETROSPECTIVE ANALYSIS OF THE SOLVD TRIALS
Dl. Dries et al., ATRIAL-FIBRILLATION IS ASSOCIATED WITH AN INCREASED RISK FOR MORTALITY AND HEART-FAILURE PROGRESSION IN PATIENTS WITH ASYMPTOMATIC AND SYMPTOMATIC LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION - A RETROSPECTIVE ANALYSIS OF THE SOLVD TRIALS, Journal of the American College of Cardiology, 32(3), 1998, pp. 695-703
Objective. This study undertook to determine if the presence of atrial
fibrillation in patients with asymptomatic and symptomatic left ventr
icular dysfunction was associated with increased mortality and, if so,
whether the increase could be attributed to progressive heart failure
or arrhythmic death. Background Atrial fibrillation is a common condi
tion in heart failure with the potential to impact hemodynamics and pr
ogression of left ventricular systolic dysfunction as well as the elec
trophysiologic substrate for arrhythmias. The available data do not co
nclusively define the effect of atrial fibrillation on prognosis in he
art failure. Methods. A retrospective analysis of the Studies of Left
Ventricular Dysfunction Prevention and Treatment Trials was con ducted
that compared patients with atrial fibrillation to those in sinus rhy
thm at baseline for the risk of all-cause mortality, progressive pump-
failure death and arrhythmic death. Results. The patients with atrial
fibrillation at baseline, compared to those in sinus rhythm, had great
er all cause mortality (34% vs. 23%, p < 0.001), death attributed to p
ump-failure (16.7% vs. 9.4%, p < 0.001) and were more likely to reach
the composite end point of death or hospitalization for heart failure
(45% vs. 33%, p < 0.001), but there was no significant difference betw
een the groups in arrhythmic deaths. After multivariate analysis, atri
al fibrillation remained significantly associated with all-cause morta
lity (relative risk [RR] 1.34, 95% confidence interval [CI] 1.12 to 1.
62, p = 0.002), progressive pump-failure death (RR 1.42, 95% CI 1.09 t
o 1.85, p = 0.01), the composite end point of death or hospitalization
for heart failure (RR 1.26, 95% CI 1.03 to 1.42, p = 0.02), but not a
rrhythmic death (RR 1.13; 95% CI 0.75 to 1.71; p = 0.55). Conclusions.
The presence of atrial fibrillation in patients with asymptomatic and
symptomatic left ventricular systolic dysfunction is associated with
an increased risk for all-cause mortality, largely explained by an inc
reased risk for pump-failure death. These data suggest that atrial fib
rillation is associated with progression of left ventricular systolic
dysfunction. (J Am Cell Cardiol 1998;32:695-703) (C) 1998 by the Ameri
can College of Cardiology.